本文言語 | English |
---|---|
ページ(範囲) | 687-689 |
ページ数 | 3 |
ジャーナル | Journal of Internal Medicine |
巻 | 292 |
号 | 4 |
DOI | |
出版ステータス | Published - 10月 2022 |
ASJC Scopus subject areas
- 内科学
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
文献へのアクセス
他のファイルとリンク
引用スタイル
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Internal Medicine, Vol. 292, No. 4, 10.2022, p. 687-689.
研究成果 › 査読
}
TY - JOUR
T1 - Three doses of mRNA COVID-19 vaccine protects from SARS-CoV-2 infections in Japan
AU - Hotta, Katsuyuki
AU - Suzuki, Etsuji
AU - Ichihara, Eiki
AU - Kiura, Katsuyuki
N1 - Funding Information: Katsuyuki Hotta received honoraria from Pfizer, AZ, Chugai, Lilly, Takeda, MSD, BMS, Ono, Taiho, and Boehringer‐Ingelheim unrelated to the work, and grants from MSD, AZ, Chugai, Lilly, BMS, and Abbvie unrelated to the work. Etsuji Suzuki has no conflicts of interest. Eiki Ichihara has received honoraria from Eli Lilly Japan, and research funds from MSD, Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Janssen Pharmaceutical K.K. unrelated to the work. Katsuyuki Kiura received consulting fees from Daiichi Sankyo Co., Ltd., honoraria from Eli Lilly Japan K.K., Novartis International AG, Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc., Ono Pharmaceutical Co., Ltd., Bristol‐Myers Squibb K.K., MSD K.K., Boehringer Ingelheim Co., Ltd., AstraZeneca K.K., and Daiichi Sankyo Co., Ltd., and grants from Daiichi Sankyo Co., Ltd., TEIJIN Pharma Ltd., Pfizer Japan Inc., SHIONOGI & Co., Ltd., Boehringer Ingelheim Co., Ltd., Nippon Kayaku Co., Ltd., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., KYORIN Pharmaceutical Co., Ltd., MSD K.K., Chugai Pharmaceutical Co., Ltd., Bristol‐Myers Squibb K.K., Merck Biopharma Co., Ltd, Novartis International AG, and Takeda Pharmaceutical Co., Ltd., unrelated to the work the work.
PY - 2022/10
Y1 - 2022/10
KW - COVID-19
KW - SARS-CoV-2
KW - vaccine
UR - http://www.scopus.com/inward/record.url?scp=85131165070&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131165070&partnerID=8YFLogxK
U2 - 10.1111/joim.13526
DO - 10.1111/joim.13526
M3 - Letter
C2 - 35612543
AN - SCOPUS:85131165070
SN - 0954-6820
VL - 292
SP - 687
EP - 689
JO - Journal of Internal Medicine
JF - Journal of Internal Medicine
IS - 4
ER -